These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 33237038)
1. Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients. Shi S; Xu M; Xi Y Aging (Albany NY); 2020 Nov; 12(23):23917-23930. PubMed ID: 33237038 [TBL] [Abstract][Full Text] [Related]
2. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma. Li XS; Nie KC; Zheng ZH; Zhou RS; Huang YS; Ye ZJ; He F; Tang Y BMC Cancer; 2021 Jan; 21(1):96. PubMed ID: 33485313 [TBL] [Abstract][Full Text] [Related]
3. Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method. Cai Q; He B; Xie H; Zhang P; Peng X; Zhang Y; Zhao Z; Wang X Cancer Med; 2020 Oct; 9(20):7488-7502. PubMed ID: 32860318 [TBL] [Abstract][Full Text] [Related]
4. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma. Zhang QH; Dai XH; Dai ZM; Cai YN Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853 [TBL] [Abstract][Full Text] [Related]
5. Genome-wide analysis of methylation CpG sites in gene promoters identified four pairs of CpGs-mRNAs associated with lung adenocarcinoma prognosis. Pan X; Ji P; Deng X; Chen L; Wang W; Li Z Gene; 2022 Feb; 810():146054. PubMed ID: 34737001 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation and mRNA expression of ZNF577 as biomarkers for the detection and prognosis of lung adenocarcinoma. Munkhjargal B; Kondo K; Soejima S; Tegshee B; Yamashita M; Kawakita N; Toba H; Takizawa H Oncol Rep; 2024 Oct; 52(4):. PubMed ID: 39129302 [TBL] [Abstract][Full Text] [Related]
7. Novel genome-wide DNA methylation profiling reveals distinct epigenetic landscape, prognostic model and cellular composition of early-stage lung adenocarcinoma. Gan J; Huang M; Wang W; Fu G; Hu M; Zhong H; Ye X; Cao Q J Transl Med; 2024 May; 22(1):428. PubMed ID: 38711158 [TBL] [Abstract][Full Text] [Related]
8. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma. Zengin T; Önal-Süzek T BMC Bioinformatics; 2020 Sep; 21(Suppl 14):368. PubMed ID: 32998690 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of GAD1 overexpression in patients with resected lung adenocarcinoma. Tsuboi M; Kondo K; Masuda K; Tange S; Kajiura K; Kohmoto T; Takizawa H; Imoto I; Tangoku A Cancer Med; 2019 Aug; 8(9):4189-4199. PubMed ID: 31207151 [TBL] [Abstract][Full Text] [Related]
10. Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients. Yang C; Zhang Y; Xu X; Li W Aging (Albany NY); 2019 Dec; 11(24):11880-11892. PubMed ID: 31852837 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression. Li H; Tong L; Tao H; Liu Z Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32031203 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma. Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390 [TBL] [Abstract][Full Text] [Related]
13. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma. Dong M; Yang Z; Li X; Zhang Z; Yin A Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775 [TBL] [Abstract][Full Text] [Related]
14. A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGA. Wang K; Liu Y; Lu G; Xiao J; Huang J; Lei L; Peng J; Li Y; Wei S Cancer Med; 2022 Jan; 11(1):281-294. PubMed ID: 34854250 [TBL] [Abstract][Full Text] [Related]
15. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis. Yang K; Wu Y BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049 [TBL] [Abstract][Full Text] [Related]
16. DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications. Xu F; He L; Zhan X; Chen J; Xu H; Huang X; Li Y; Zheng X; Lin L; Chen Y Aging (Albany NY); 2020 Nov; 12(24):25275-25293. PubMed ID: 33234739 [TBL] [Abstract][Full Text] [Related]
17. Aberrant CpG-methylation affects genes expression predicting survival in lung adenocarcinoma. He W; Ju D; Jie Z; Zhang A; Xing X; Yang Q Cancer Med; 2018 Nov; 7(11):5716-5726. PubMed ID: 30353687 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype. Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282 [No Abstract] [Full Text] [Related]
19. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma. Xu XL; Gong Y; Zhao DP Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913 [TBL] [Abstract][Full Text] [Related]
20. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma. Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]